Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-28 @ 4:27 AM
Study NCT ID:
NCT00782106
Status:
COMPLETED
Last Update Posted:
2021-05-05
First Post:
2008-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously
Sponsor:
Baxalta now part of Shire
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2007-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-29
First Submit QC Date:
None
Study First Post Date:
2008-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-30
Last Update Post Date:
2021-05-05
Last Update Post Date Type:
ACTUAL